Pharmaceutical Manufacturing News and Research

RSS

Two researchers win Humanity in Science prize for developing new antimalarial drug production methods

Prof. Dr. Peter H. Seeberger, a director at the Max Planck Institute of Colloids and Interfaces in Potsdam and a professor of chemistry at Freie Universität Berlin, and Prof. Dr.-Ing. Andreas Seidel-Morgenstern, a director at the Max Planck Institute for Dynamics of Complex Technical Systems in Magdeburg and a professor of chemical engineering at the Otto-von Guericke-University in Magdeburg, won the Humanity in Science prize for their groundbreaking work in developing new production methods for antimalarial drugs.

12 Mar 2015

Single-step fermentative method may facilitate industrial-scale statin drug production

University of Manchester researchers, together with industrial partner DSM, have developed a single-step fermentative method for the production of leading cholesterol-lowering drug, pravastatin, which will facilitate industrial-scale statin drug production.

27 Feb 2015

Cannabis Science highlights more attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm

Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, highlights additional attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm held at the African Union, in Washington DC, on February 6, 2015.

12 Feb 2015

AMRI awarded NIH contract for drug development services

AMRI today announced it received a 10-year federal contract award from the National Institutes of Health for drug development and manufacturing services. This NIH/National Institute of Neurological Disorders and Stroke award will support NIH's Drug Manufacturing and Formulation Program (DMFP), which is a component of the Blueprint Neurotherapeutics Network (BPN).

19 Jan 2015

Tianyin Pharmaceutical's Qionglai Facility completes official GMP site visit by CFDA

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that its Qionglai Facility (QLF) has successfully completed the official site visit by the China Food & Drug Administration's (CFDA) for its Good Manufacturing Practice (GMP) certification.

29 Sep 2014

Pharmaceutical Manufacturing Technology Centre launched in Ireland

The Minister for Skills, Research and Innovation, Damien English TD, today (Friday 12th September 2014) launched the Pharmaceutical Manufacturing Technology Centre (PMTC).

16 Sep 2014

Kinex Pharmaceuticals acquires QuaDPharma

Kinex Pharmaceuticals Inc. today announced that it has completed the acquisition of QuaDPharma, LLC., a Western New York based privately-held company specializing in pharmaceutical manufacturing, analytical and support services to the pharmaceutical and biotech industries. Financial terms of the transaction were not disclosed.

9 Sep 2014

PharmaBoardroom's "Healthcare and Life Sciences Review Poland 2014" report

PharmaBoardroom's "Healthcare and Life Sciences Review Poland 2014", is now available for free download. The report explores one of Europe's largest pharma markets, and looks at the delicate balance between a strong and growing economy, and healthcare legislation that many complain is negatively affecting the pharmaceutical market.

17 Jul 2014

Propak Asia 2014 to be held at BITEC on June 11-14

ProPak Asia is Asia's No. 1 international food, drink and pharmaceutical processing, filling and packaging technology event, to take place for its successful 22nd edition on 11 to 14 June at Bangkok International Trade and Exhibition Centre (BITEC).

4 Jun 2014

Emilia Group completes acquisition of Pharma Pac's strategic assets

Emilia Group is pleased to announce the recent acquisition of strategic assets of Pharma Pac LLC, an OTC private brand and contract manufacturer, located in DeKalb, MS. The new entity is named Emilia Resources LLC and will operate as a manufacturing company of pharmaceutical and cosmetic products that will combine with Emilia Personal Care's strength in sales, marketing, supply chain and customer service.

28 Apr 2014

Scientists discover a new process for making fast, efficient crystalline organic semiconductors

Sometimes engineers invent something before they fully comprehend why it works. To understand the "why," they must often create new tools and techniques in a virtuous cycle that improves the original invention while also advancing basic scientific knowledge.

22 Apr 2014

Vietnam's pharmaceutical market records growth rate of nearly 17% in 2013

Decision Resources Group finds that Vietnam is currently one of the fastest growing pharmaceutical markets in Southeast Asia, recording a growth rate of nearly 17 percent and exceeding $3 billion in size in 2013. Increasing affluence, a rapidly aging population and the steady extension of public health insurance are among factors that are driving demand for prescription medicines.

22 Apr 2014

‘Profile America’ features world's most important medicine, insulin

One of world's most important medicines — insulin —became available for general use this month in 1923, saving the lives of millions of people suffering from diabetes. Insulin is a hormone produced by the pancreas and is critical in the processing of carbohydrates in the human body. I

22 Apr 2014

CPhI Russia Pharma Expo to be held at St. Petersburg from 16 to 17 April, 2014

Leading events organizer, UBM Live, along with partner RESTEC, announces that CPhI Russia @ IPhEB is returning for a second year to St. Petersburg, from 16th to 17th April 2014. The event will co-locate with ICSE, P-MEC and InnoPack, creating Russia's most comprehensive meeting point for the pharmaceutical industry.

9 Apr 2014

BioAlliance Pharma, Daewoong sign new licensing agreement for commercialization of Sitavig in South Korea

BioAlliance Pharma SA, an innovative Company specialized in the development of drugs in orphan oncology diseases, today announces an exclusive supply and license agreement for Sitavig® (Acyclovir Lauriad®) with Daewoong Pharmaceutical Co., Ltd. for commercialization rights in South Korea.

2 Apr 2014

Tetraphase Pharmaceuticals reports net loss of $11.3 million for Q4 2013

Tetraphase Pharmaceuticals, Inc. today reported financial results for the quarter and full year ended December 31, 2013.

6 Mar 2014

Ajoene in garlic prevents bacteria from destroying white blood cells

Aggressive multi-resistant infections constitute an increasing health problem all over the world. Bacteria are developing resistance at an alarming pace, so new pharmaceuticals that can combat this threat are in great demand.

19 Feb 2014

CytoDyn submits PRO 140 Phase 2b trial protocol to FDA for treatment substitution in HIV patients

CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today that the Company has submitted a Phase 2b clinical trial protocol, for its lead product candidate, PRO 140, to the U.S. Food and Drug Administration for treatment substitution in patients with Human Immunodeficiency Virus (HIV).

19 Feb 2014

Researchers create promising compound for cancer treatment

A promising compound for cancer treatment has been syntesised in a laboratory by an RMIT University researcher during his PhD research.

9 Feb 2014

TSRI scientists discover unusual protein that probably helps some bacteria evade immune response

A team led by scientists at The Scripps Research Institute (TSRI) has discovered an unusual bacterial protein that attaches to virtually any antibody and prevents it from binding to its target. Protein M, as it is called, probably helps some bacteria evade the immune response and establish long-term infections.

7 Feb 2014

Pharmaceutical Manufacturing News and Research

Two researchers win Humanity in Science prize for developing new antimalarial drug production methods

Single-step fermentative method may facilitate industrial-scale statin drug production

Cannabis Science highlights more attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm

AMRI awarded NIH contract for drug development services

Tianyin Pharmaceutical's Qionglai Facility completes official GMP site visit by CFDA

Pharmaceutical Manufacturing Technology Centre launched in Ireland

Kinex Pharmaceuticals acquires QuaDPharma

PharmaBoardroom's "Healthcare and Life Sciences Review Poland 2014" report

Propak Asia 2014 to be held at BITEC on June 11-14

Emilia Group completes acquisition of Pharma Pac's strategic assets

Scientists discover a new process for making fast, efficient crystalline organic semiconductors

Vietnam's pharmaceutical market records growth rate of nearly 17% in 2013

‘Profile America’ features world's most important medicine, insulin

CPhI Russia Pharma Expo to be held at St. Petersburg from 16 to 17 April, 2014

BioAlliance Pharma, Daewoong sign new licensing agreement for commercialization of Sitavig in South Korea

Tetraphase Pharmaceuticals reports net loss of $11.3 million for Q4 2013

Ajoene in garlic prevents bacteria from destroying white blood cells

CytoDyn submits PRO 140 Phase 2b trial protocol to FDA for treatment substitution in HIV patients

Researchers create promising compound for cancer treatment

TSRI scientists discover unusual protein that probably helps some bacteria evade immune response

A guide to density measurement excellence eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®